proline and Prostatic Neoplasms

proline has been researched along with Prostatic Neoplasms in 28 studies

Research

Studies (28)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	3 (10.71)	18.2507
2000's	13 (46.43)	29.6817
2010's	7 (25.00)	24.3611
2020's	5 (17.86)	2.80

Authors

Authors	Studies
Guo, S; Huang, B; Jiang, S; Mao, X; Mo, C; Zhuang, J	1
Hong, X; Hu, Q; Jia, R; Mao, L; Xu, L	1
Juárez-López, D; Schcolnik-Cabrera, A	1
Almeida, MAP; Batista, AA; Campos, VNS; das Chagas Alves Lima, F; de Azevedo Dos Santos, APS; de Sousa, IH; Leite, CM; Lopes, AJO; Maciel-Silva, VL; Mourão, PS; Pereira, SRF; Vale, AAM	1
Angel, PM; Ball, LE; Bethard, JR; Drake, RR; Hughes-Halbert, C; Jefferson, M; Spruill, L	1
Braun, F; Dobitz, S; Kroll, C; Maecke, HR; Mansi, R; Wennemers, H	1
Adam, V; Cernei, N; Eckschlager, T; Gumulec, J; Heger, Z; Hrabec, R; Kizek, R; Masarik, M; Zitka, O	1
Di, JM; Fang, YQ; Gao, X; Liu, XP; Pang, J; Pu, XY; Ruan, XX; Zhang, Y	1
Miltyk, W; Skrzydlewska, E; Stankiewicz-Kranc, A	1
Ahaghotu, C; Apprey, V; Bonney, G; Dunston, GM; Josey, D; Mason, T; McLauchlin, A; Ricks-Santi, L	1
Rathee, D; Rathee, P; Rathee, S	1
Cheng, X; Gamagedara, S; Jiang, Y; Kaczmarek, AT; Ma, Y; Rupasinghe, M	1
Bieberich, CJ; Guan, B; Mutton, LN; Rao, V	1
Gunawardena, K; Meikle, AW; Murray, DK; Swope, RE	1
Bhattacharyya, RS; Stern, PH	1
Ambrosone, CB; Barnhart, S; Carroll, A; Carter, W; Emerson, GL; Greene, G; Johnson, DE; Kadlubar, FF; Lang, NP; Lehman, T; Modali, R; Rasheed, AA; Ratnasinghe, LD; Runnells, G; Stone, A	1
Campbell, LD; Gunawardena, K; Meikle, AW	1
Cauley, JA; Ferrell, RE; Modugno, F; Moffett, SP; Trump, DL; Weissfeld, JL; Zmuda, JM	1
Bar-Shira, A; Mabjeesh, NJ; Matzkin, H; Orr-Urtreger, A	1
Ivanov, V; Kalinovsky, T; Niedzwiecki, A; Rath, M; Roomi, MW	1
Altshuler, D; Bell, DW; Daly, MB; Freedman, ML; Garber, JE; Godwin, AK; Haber, DA; Haiman, CA; Harris, PL; Haserlat, SM; Henderson, BE; Kim, SH; Le Marchand, L; Niendorf, KB; Olopade, OI; Schiripo, TA; Sgroi, DC; Smith, MR; Wahrer, DC	1
Li, J; Wang, KR; Wang, R; Yan, JX; Zhang, BZ; Zhang, W	1
Kostenuik, PJ; Orr, FW; Sanchez-Sweatman, O; Singh, G	1
Beham, AW; Brisbay, S; Bruckheimer, EM; Chiao, PJ; Herrmann, JL; McDonnell, TJ; Rands, MT; Sarkiss, M	1
Anderson, JB; Bowsher, WG; Gillatt, DA; Imbimbo, BP; Kaisary, AV; Malone, PR	1
Gunawardena, K; Meikle, AW; Murray, DK	2
Ackermann, R; Börner, AR; Coenen, HH; Hamacher, K; Herzog, H; Langen, KJ; Müller-Mattheis, V	1

Reviews

1 review(s) available for proline and Prostatic Neoplasms

Article	Year
Dual contribution of the mTOR pathway and of the metabolism of amino acids in prostate cancer. Cellular oncology (Dordrecht), 2022, Volume: 45, Issue:5 Topics: Amino Acids; Arginine; Carbohydrates; Glutamine; Humans; Leucine; Lipids; Male; Proline; Prostatic Neoplasms; Sarcosine; Serine; TOR Serine-Threonine Kinases	2022

Trials

1 trial(s) available for proline and Prostatic Neoplasms

Article	Year
Pharmacodynamics of a long acting depot preparation of avorelin in patients with prostate cancer. Avorelin Study Group. The Journal of urology, 1999, Volume: 162, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Delayed-Action Preparations; Humans; Male; Middle Aged; Proline; Prostatic Neoplasms; Receptors, LHRH; Time Factors	1999

Other Studies

26 other study(ies) available for proline and Prostatic Neoplasms

Article	Year
LncRNA nuclear-enriched abundant transcript 1 shuttled by prostate cancer cells-secreted exosomes initiates osteoblastic phenotypes in the bone metastatic microenvironment via miR-205-5p/runt-related transcription factor 2/splicing factor proline- and glu Clinical and translational medicine, 2021, Volume: 11, Issue:8 Topics: Animals; Bone Neoplasms; Core Binding Factor Alpha 1 Subunit; Disease Models, Animal; Exosomes; Glutamine; Humans; Male; Mice; MicroRNAs; Osteoblasts; Phenotype; Polypyrimidine Tract-Binding Protein; Proline; Prostatic Neoplasms; RNA Splicing Factors; RNA, Long Noncoding; Tumor Microenvironment	2021
Prostate-specific membrane antigen modulates the progression of prostate cancer by regulating the synthesis of arginine and proline and the expression of androgen receptors and Fos proto-oncogenes. Bioengineered, 2022, Volume: 13, Issue:1 Topics: Animals; Antigens, Surface; Arginine; Cell Line, Tumor; Cell Movement; Cell Proliferation; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Glutamate Carboxypeptidase II; Humans; Male; Metabolomics; Mice; Neoplasm Transplantation; Proline; Prostatic Neoplasms; Proto-Oncogene Proteins c-fos; Receptors, Androgen	2022
Ruthenium (II) complexes with N, O-chelating proline and threonine ligands cause selective cytotoxicity by the induction of genomic instability, cell cycle arrest and apoptosis in breast and prostate tumor cells. Toxicology in vitro : an international journal published in association with BIBRA, 2020, Volume: 62 Topics: Amino Acid Transport System ASC; Apoptosis; Breast Neoplasms; Cell Cycle Checkpoints; Cell Line, Tumor; Chelating Agents; DNA Damage; Female; Genomic Instability; Humans; Ligands; Male; Minor Histocompatibility Antigens; Molecular Docking Simulation; Proline; Prostatic Neoplasms; Ruthenium Compounds; Threonine	2020
Zonal regulation of collagen-type proteins and posttranslational modifications in prostatic benign and cancer tissues by imaging mass spectrometry. The Prostate, 2020, Volume: 80, Issue:13 Topics: Aged; Amino Acid Sequence; Autoantigens; Collagen; Collagen Type I; Collagen Type I, alpha 1 Chain; Collagen Type III; Collagen Type IV; Collagen Type VIII; Collagen Type XVII; Disease Progression; Fibrillar Collagens; Humans; Hydroxylation; Male; Middle Aged; Neoplasm Proteins; Non-Fibrillar Collagens; Proline; Prostate; Prostatectomy; Prostatic Neoplasms; Protein Processing, Post-Translational; Proteomics; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Spectroscopy, Fourier Transform Infrared	2020
Hybrid bombesin analogues: combining an agonist and an antagonist in defined distances for optimized tumor targeting. Journal of the American Chemical Society, 2013, Nov-13, Volume: 135, Issue:45 Topics: Animals; Bombesin; Cell Line, Tumor; Drug Delivery Systems; Humans; Male; Mice; Mice, Nude; Proline; Prostatic Neoplasms; Receptors, Bombesin	2013
Determination of common urine substances as an assay for improving prostate carcinoma diagnostics. Oncology reports, 2014, Volume: 31, Issue:4 Topics: Adenocarcinoma; Aged; Aged, 80 and over; Biomarkers, Tumor; Chromatography, Liquid; Disease Progression; Humans; Male; Middle Aged; Proline; Prostate-Specific Antigen; Prostatic Neoplasms; Sarcosine; Uric Acid	2014
Toll-like receptor 9 agonists promote IL-8 and TGF-beta1 production via activation of nuclear factor kappaB in PC-3 cells. Cancer genetics and cytogenetics, 2009, Jul-15, Volume: 192, Issue:2 Topics: Cell Line, Tumor; Cell Nucleus; Chloroquine; Humans; Interleukin-8; Male; NF-kappa B; Oligodeoxyribonucleotides; Proline; Prostatic Neoplasms; Protein Transport; Signal Transduction; Thiocarbamates; Toll-Like Receptor 9; Transforming Growth Factor beta1	2009
Comparison of influence of carmustine and new proline analog of nitrosourea on antioxidant system in breast carcinoma cells (MCF-7). Drug and chemical toxicology, 2010, Volume: 33, Issue:1 Topics: Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Breast Neoplasms; Calcium; Carmustine; Cell Line, Tumor; Cell Survival; Chemotactic Factors; Drug Screening Assays, Antitumor; Humans; Hydrogen Peroxide; Lipid Peroxidation; Male; Nitrosourea Compounds; Oxidation-Reduction; Oxidative Stress; Oxygen; Proline; Prostatic Neoplasms; Sulfhydryl Compounds; Tetrazolium Salts	2010
p53 Pro72Arg polymorphism and prostate cancer in men of African descent. The Prostate, 2010, Dec-01, Volume: 70, Issue:16 Topics: Adult; Aged; Aged, 80 and over; Amino Acid Substitution; Arginine; Black or African American; DNA Primers; Ethnicity; Humans; Male; Middle Aged; Models, Genetic; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Proline; Prostatic Neoplasms; Risk Factors; Tumor Suppressor Protein p53	2010
In vitro anticancer activity of stachydrine isolated from Capparis decidua on prostate cancer cell lines. Natural product research, 2012, Volume: 26, Issue:18 Topics: Capparis; Cell Line, Tumor; Cell Proliferation; Humans; Male; Proline; Prostatic Neoplasms; Receptors, CXCR4; Reverse Transcriptase Polymerase Chain Reaction	2012
Validation study of urinary metabolites as potential biomarkers for prostate cancer detection. Bioanalysis, 2012, Volume: 4, Issue:10 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Case-Control Studies; Chromatography, High Pressure Liquid; Creatinine; Diagnosis, Differential; Female; Glycerophosphates; Humans; Kynurenine; Male; Metabolomics; Middle Aged; Multivariate Analysis; Neoplasm Grading; Proline; Prostate-Specific Antigen; Prostatic Neoplasms; Tandem Mass Spectrometry; Uracil; Urinary Bladder Neoplasms	2012
Proline-mediated proteasomal degradation of the prostate-specific tumor suppressor NKX3.1. The Journal of biological chemistry, 2012, Oct-19, Volume: 287, Issue:43 Topics: Amino Acid Substitution; Antineoplastic Agents; Cell Line, Tumor; Homeodomain Proteins; Humans; Male; Mutation, Missense; Peptides; Phosphorylation; Proline; Prostatic Neoplasms; Proteasome Endopeptidase Complex; Protein Processing, Post-Translational; Proteolysis; Transcription Factors; Tumor Suppressor Proteins; Ubiquitin; Ubiquitination	2012
Inhibition of nuclear factor kappaB induces apoptosis following treatment with tumor necrosis factor alpha and an antioxidant in human prostate cancer cells. Cancer detection and prevention, 2002, Volume: 26, Issue:3 Topics: Antineoplastic Agents; Apoptosis; Computer Graphics; Humans; Male; Neoplasm Proteins; NF-kappa B; Proline; Prostatic Neoplasms; Protein Biosynthesis; Proteins; Thiocarbamates; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha	2002
IGF-I and MAP kinase involvement in the stimulatory effects of LNCaP prostate cancer cell conditioned media on cell proliferation and protein synthesis in MC3T3-E1 osteoblastic cells. Journal of cellular biochemistry, 2003, Dec-01, Volume: 90, Issue:5 Topics: Animals; Cell Division; Culture Media, Conditioned; Enzyme Inhibitors; Humans; Insulin-Like Growth Factor I; Male; Mice; Mitogen-Activated Protein Kinases; Osteoblasts; Proline; Prostatic Neoplasms; Signal Transduction; Thymidine; Tumor Cells, Cultured	2003
CYP3A43 Pro(340)Ala polymorphism and prostate cancer risk in African Americans and Caucasians. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2005, Volume: 14, Issue:5 Topics: Adult; Aged; Alanine; Arkansas; Aryl Hydrocarbon Hydroxylases; Black or African American; Genotype; Humans; Incidence; Male; Middle Aged; Odds Ratio; Polymerase Chain Reaction; Polymorphism, Genetic; Proline; Prostatic Neoplasms; White People	2005
Antiandrogen-like actions of an antioxidant on survivin, Bcl-2 and PSA in human prostate cancer cells. Cancer detection and prevention, 2005, Volume: 29, Issue:4 Topics: Androgen Antagonists; Antineoplastic Agents; Antioxidants; Apoptosis; Blotting, Northern; Blotting, Western; Cell Growth Processes; Cell Survival; Electrophoretic Mobility Shift Assay; Humans; Inhibitor of Apoptosis Proteins; Male; Microtubule-Associated Proteins; Neoplasm Proteins; Neoplasms, Hormone-Dependent; NF-kappa B; Proline; Prostate-Specific Antigen; Prostatic Neoplasms; Proto-Oncogene Proteins c-bcl-2; Receptors, Androgen; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Survivin; Testosterone; Thiocarbamates; Tumor Cells, Cultured	2005
Peroxisome proliferator-activated receptor-gamma polymorphism, body mass and prostate cancer risk: evidence for gene-environment interaction. Oncology, 2006, Volume: 70, Issue:3 Topics: Adult; Aged; Alanine; Body Mass Index; Case-Control Studies; Genotype; Humans; Insulin; Male; Middle Aged; Odds Ratio; Polymorphism, Genetic; PPAR gamma; Predictive Value of Tests; Proline; Prostatic Neoplasms; Waist-Hip Ratio	2006
The homozygous P582S mutation in the oxygen-dependent degradation domain of HIF-1 alpha is associated with increased risk for prostate cancer. The Prostate, 2007, Jan-01, Volume: 67, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Cell Hypoxia; Female; Gene Frequency; Genetic Predisposition to Disease; Homozygote; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Jews; Male; Middle Aged; Oxygen; Point Mutation; Proline; Prostatic Neoplasms; Protein Structure, Tertiary; Risk Factors; Serine	2007
Anti-tumor effect of ascorbic acid, lysine, proline, arginine, and epigallocatechin gallate on prostate cancer cell lines PC-3, LNCaP, and DU145. Research communications in molecular pathology and pharmacology, 2004, Volume: 115-116 Topics: Antioxidants; Arginine; Ascorbic Acid; Catechin; Cell Line, Tumor; Cell Proliferation; Chemistry, Pharmaceutical; Collagen; Dose-Response Relationship, Drug; Drug Combinations; Drug Synergism; Formazans; Humans; Laminin; Lysine; Male; Matrix Metalloproteinases; Neoplasm Invasiveness; Proline; Prostatic Neoplasms; Proteoglycans; Tetrazolium Salts	2004
Genetic and functional analysis of CHEK2 (CHK2) variants in multiethnic cohorts. International journal of cancer, 2007, Dec-15, Volume: 121, Issue:12 Topics: Adult; Age of Onset; Aged; Asian People; Black or African American; Breast Neoplasms; Case-Control Studies; Checkpoint Kinase 2; DNA Mutational Analysis; DNA, Complementary; Female; Gene Frequency; Genetic Predisposition to Disease; Germ-Line Mutation; Hawaii; Hispanic or Latino; Histidine; Humans; Isoleucine; Leucine; Male; Middle Aged; Mutation; Mutation, Missense; Predictive Value of Tests; Proline; Prostatic Neoplasms; Protein Serine-Threonine Kinases; Risk Assessment; Risk Factors; Threonine; Tyrosine; United States; White People	2007
Antitumor effects, cell selectivity and structure-activity relationship of a novel antimicrobial peptide polybia-MPI. Peptides, 2008, Volume: 29, Issue:6 Topics: Amino Acid Substitution; Animals; Anti-Bacterial Agents; Antineoplastic Agents; Cell Culture Techniques; Cell Line, Tumor; Cell Membrane; Cell Proliferation; Culture Media, Serum-Free; Dose-Response Relationship, Drug; Drug Design; Fibroblasts; Gram-Negative Bacteria; Gram-Positive Bacteria; Hemolysis; Humans; L-Lactate Dehydrogenase; Male; Mice; NIH 3T3 Cells; Proline; Prostatic Neoplasms; Protein Conformation; Protein Structure, Secondary; Rats; Structure-Activity Relationship; Urinary Bladder Neoplasms; Wasp Venoms; Wasps	2008
Bone cell matrix promotes the adhesion of human prostatic carcinoma cells via the alpha 2 beta 1 integrin. Clinical & experimental metastasis, 1996, Volume: 14, Issue:1 Topics: Amino Acid Sequence; Antibodies, Monoclonal; Bone and Bones; Carcinoma; Cell Adhesion; Cells, Cultured; Collagen; Extracellular Matrix; Humans; Integrin beta1; Male; Molecular Sequence Data; Osteoblasts; Osteosarcoma; Peptides; Phorbol Esters; Proline; Prostatic Neoplasms; Transforming Growth Factor beta; Tumor Cells, Cultured	1996
Bcl-2 suppresses apoptosis resulting from disruption of the NF-kappa B survival pathway. Experimental cell research, 1997, Nov-25, Volume: 237, Issue:1 Topics: Antineoplastic Agents; Antioxidants; Apoptosis; Cell Survival; DNA-Binding Proteins; Humans; I-kappa B Proteins; Kinetics; Male; NF-kappa B; NF-KappaB Inhibitor alpha; Proline; Prostatic Neoplasms; Proto-Oncogene Proteins c-bcl-2; Recombinant Fusion Proteins; Recombinant Proteins; Signal Transduction; Thiocarbamates; Transfection; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha	1997
Vitamin E and other antioxidants inhibit human prostate cancer cells through apoptosis. The Prostate, 2000, Sep-01, Volume: 44, Issue:4 Topics: Androgens; Antineoplastic Agents; Antioxidants; Apoptosis; Cell Division; Ditiocarb; Drug Interactions; Epithelial Cells; Growth Inhibitors; Humans; Male; Necrosis; Neoplasms, Hormone-Dependent; Proline; Prostatic Neoplasms; Testosterone; Thiocarbamates; Tumor Cells, Cultured; Vitamin E	2000
Uptake of cis-4-[18F]fluoro-L-proline in urologic tumors. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2001, Volume: 42, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Renal Cell; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Penile Neoplasms; Pilot Projects; Proline; Prostatic Neoplasms; Radiopharmaceuticals; Tomography, Emission-Computed	2001
Testosterone is a potential augmentor of antioxidant-induced apoptosis in human prostate cancer cells. Cancer detection and prevention, 2002, Volume: 26, Issue:2 Topics: Androgens; Antineoplastic Agents; Antioxidants; Apoptosis; Cell Division; Cell Nucleus; Electrophoretic Mobility Shift Assay; Epithelial Cells; Humans; Male; Neoplasms, Hormone-Dependent; NF-kappa B; Proline; Prostate-Specific Antigen; Prostatic Neoplasms; Receptors, Androgen; Testosterone; Thiocarbamates; Tumor Cells, Cultured; Up-Regulation	2002